| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 119 | 2024 | 13262 | 6.220 |
Why?
|
| Carcinoma, Pancreatic Ductal | 67 | 2024 | 1724 | 5.720 |
Why?
|
| Pancreatic Neoplasms | 96 | 2024 | 5351 | 5.270 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 57 | 2024 | 5251 | 4.480 |
Why?
|
| Adenocarcinoma, Mucinous | 38 | 2024 | 517 | 4.370 |
Why?
|
| Adenocarcinoma | 63 | 2024 | 6315 | 3.980 |
Why?
|
| Pancreatic Cyst | 17 | 2021 | 367 | 2.430 |
Why?
|
| Barrett Esophagus | 14 | 2014 | 490 | 2.080 |
Why?
|
| Immunohistochemistry | 55 | 2022 | 11071 | 1.820 |
Why?
|
| Pancreas | 27 | 2021 | 1677 | 1.630 |
Why?
|
| Neoplasm Staging | 43 | 2024 | 11152 | 1.500 |
Why?
|
| Pancreatic Ducts | 13 | 2022 | 329 | 1.430 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 8 | 2023 | 194 | 1.400 |
Why?
|
| Small Cell Lung Carcinoma | 8 | 2023 | 421 | 1.400 |
Why?
|
| Cytodiagnosis | 9 | 2021 | 442 | 1.390 |
Why?
|
| Carcinoma, Papillary | 18 | 2021 | 785 | 1.390 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 12 | 2024 | 1088 | 1.360 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 16 | 2017 | 1613 | 1.310 |
Why?
|
| Esophageal Neoplasms | 13 | 2018 | 1648 | 1.280 |
Why?
|
| Pancreatectomy | 19 | 2021 | 810 | 1.270 |
Why?
|
| Precancerous Conditions | 12 | 2017 | 977 | 1.250 |
Why?
|
| Lung | 25 | 2024 | 9994 | 1.140 |
Why?
|
| Neoplasm Invasiveness | 29 | 2024 | 3618 | 1.120 |
Why?
|
| Mutation | 59 | 2024 | 29932 | 1.070 |
Why?
|
| Antibodies | 5 | 2021 | 2421 | 0.990 |
Why?
|
| Esophagus | 12 | 2014 | 1023 | 0.960 |
Why?
|
| Humans | 386 | 2024 | 760621 | 0.950 |
Why?
|
| Neoplasm Recurrence, Local | 23 | 2022 | 9276 | 0.940 |
Why?
|
| Pathology | 3 | 2024 | 270 | 0.940 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 8 | 2024 | 502 | 0.870 |
Why?
|
| Carcinoma in Situ | 7 | 2019 | 796 | 0.860 |
Why?
|
| Esophagoscopy | 7 | 2014 | 390 | 0.850 |
Why?
|
| Microsatellite Instability | 6 | 2016 | 715 | 0.850 |
Why?
|
| Proto-Oncogene Proteins B-raf | 10 | 2021 | 2053 | 0.820 |
Why?
|
| Aged | 166 | 2024 | 169152 | 0.810 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 19 | 2023 | 1728 | 0.800 |
Why?
|
| Gastric Mucosa | 12 | 2019 | 599 | 0.790 |
Why?
|
| Tumor Microenvironment | 19 | 2024 | 3844 | 0.790 |
Why?
|
| Drug Resistance, Neoplasm | 23 | 2024 | 5253 | 0.780 |
Why?
|
| Prognosis | 48 | 2024 | 29658 | 0.780 |
Why?
|
| Thoracic Neoplasms | 1 | 2024 | 266 | 0.770 |
Why?
|
| Biopsy | 28 | 2022 | 6771 | 0.760 |
Why?
|
| Alveolitis, Extrinsic Allergic | 4 | 2017 | 62 | 0.760 |
Why?
|
| Protein Kinase Inhibitors | 28 | 2022 | 5643 | 0.750 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2018 | 117 | 0.740 |
Why?
|
| Aged, 80 and over | 93 | 2024 | 58995 | 0.730 |
Why?
|
| Middle Aged | 170 | 2024 | 220352 | 0.720 |
Why?
|
| Diagnosis, Differential | 36 | 2022 | 12965 | 0.700 |
Why?
|
| Pathology, Molecular | 2 | 2020 | 329 | 0.700 |
Why?
|
| Lung Diseases, Interstitial | 5 | 2024 | 911 | 0.690 |
Why?
|
| Male | 208 | 2024 | 359744 | 0.680 |
Why?
|
| Female | 201 | 2024 | 391270 | 0.620 |
Why?
|
| Stomach Neoplasms | 10 | 2019 | 1423 | 0.610 |
Why?
|
| Colorectal Neoplasms | 14 | 2019 | 6853 | 0.600 |
Why?
|
| Tomography, Optical Coherence | 14 | 2022 | 2884 | 0.580 |
Why?
|
| Antibodies, Monoclonal | 10 | 2021 | 9185 | 0.570 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 448 | 0.550 |
Why?
|
| Cyst Fluid | 5 | 2021 | 83 | 0.540 |
Why?
|
| ras Proteins | 8 | 2020 | 1052 | 0.540 |
Why?
|
| Epithelial Cells | 9 | 2021 | 3663 | 0.540 |
Why?
|
| Pathology, Clinical | 9 | 2017 | 375 | 0.530 |
Why?
|
| Pancreatitis | 9 | 2015 | 1100 | 0.530 |
Why?
|
| Photochemotherapy | 7 | 2020 | 820 | 0.520 |
Why?
|
| Translocation, Genetic | 3 | 2016 | 1388 | 0.510 |
Why?
|
| Intestinal Mucosa | 14 | 2020 | 3022 | 0.500 |
Why?
|
| Cystadenoma, Serous | 3 | 2021 | 100 | 0.500 |
Why?
|
| Adult | 114 | 2024 | 219994 | 0.490 |
Why?
|
| Immunodominant Epitopes | 1 | 2016 | 241 | 0.490 |
Why?
|
| Adenocarcinoma, Papillary | 5 | 2014 | 84 | 0.490 |
Why?
|
| Endosonography | 11 | 2023 | 607 | 0.480 |
Why?
|
| Pyrazoles | 13 | 2022 | 1999 | 0.470 |
Why?
|
| Celiac Disease | 4 | 2020 | 822 | 0.470 |
Why?
|
| Carcinoma, Squamous Cell | 14 | 2024 | 4024 | 0.470 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2016 | 311 | 0.460 |
Why?
|
| Pain, Intractable | 1 | 2015 | 132 | 0.460 |
Why?
|
| Pleural Neoplasms | 4 | 2022 | 609 | 0.460 |
Why?
|
| Protein-Tyrosine Kinases | 10 | 2023 | 2418 | 0.450 |
Why?
|
| Aspergillus flavus | 1 | 2013 | 14 | 0.440 |
Why?
|
| Carcinoma | 3 | 2021 | 2331 | 0.440 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 3804 | 0.430 |
Why?
|
| Reproducibility of Results | 23 | 2022 | 20080 | 0.430 |
Why?
|
| In Situ Hybridization, Fluorescence | 16 | 2022 | 2506 | 0.430 |
Why?
|
| Observer Variation | 9 | 2020 | 2601 | 0.430 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 13 | 2024 | 11712 | 0.420 |
Why?
|
| Neoplasm Proteins | 4 | 2021 | 3610 | 0.420 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2023 | 346 | 0.420 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 5791 | 0.410 |
Why?
|
| Gene Rearrangement | 5 | 2016 | 1122 | 0.410 |
Why?
|
| Esophageal Cyst | 1 | 2012 | 13 | 0.410 |
Why?
|
| Mucins | 5 | 2009 | 568 | 0.410 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2012 | 33 | 0.400 |
Why?
|
| Pathology, Surgical | 4 | 2016 | 151 | 0.400 |
Why?
|
| Retrospective Studies | 57 | 2024 | 80372 | 0.390 |
Why?
|
| Aspergillus fumigatus | 1 | 2013 | 156 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 23 | 2024 | 8515 | 0.390 |
Why?
|
| Tissue Array Analysis | 5 | 2019 | 551 | 0.390 |
Why?
|
| Toxoplasmosis | 1 | 2012 | 93 | 0.390 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2023 | 4490 | 0.390 |
Why?
|
| Tomography, X-Ray Computed | 30 | 2024 | 20509 | 0.390 |
Why?
|
| Colonic Neoplasms | 8 | 2019 | 2526 | 0.390 |
Why?
|
| Immunotherapy | 11 | 2024 | 4642 | 0.380 |
Why?
|
| Brain Abscess | 1 | 2012 | 120 | 0.370 |
Why?
|
| Pulmonary Fibrosis | 5 | 2017 | 506 | 0.370 |
Why?
|
| Sensitivity and Specificity | 23 | 2021 | 14660 | 0.370 |
Why?
|
| Autopsy | 3 | 2020 | 1007 | 0.370 |
Why?
|
| Colon, Sigmoid | 2 | 2010 | 124 | 0.370 |
Why?
|
| Lung Diseases, Fungal | 1 | 2011 | 126 | 0.370 |
Why?
|
| Cryptococcosis | 1 | 2011 | 104 | 0.370 |
Why?
|
| Fatal Outcome | 5 | 2020 | 1832 | 0.360 |
Why?
|
| Conscious Sedation | 1 | 2015 | 529 | 0.360 |
Why?
|
| Cell Line, Tumor | 31 | 2024 | 16939 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-met | 5 | 2020 | 567 | 0.360 |
Why?
|
| Pyridines | 9 | 2020 | 2879 | 0.360 |
Why?
|
| Pemphigus | 1 | 2011 | 116 | 0.360 |
Why?
|
| Xenograft Model Antitumor Assays | 15 | 2020 | 3584 | 0.350 |
Why?
|
| Adenoma | 6 | 2021 | 2148 | 0.350 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2022 | 2802 | 0.350 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 393 | 0.340 |
Why?
|
| Genes, erbB-1 | 3 | 2017 | 160 | 0.340 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2012 | 156 | 0.340 |
Why?
|
| Antineoplastic Agents | 17 | 2020 | 13630 | 0.340 |
Why?
|
| Esophagogastric Junction | 2 | 2011 | 341 | 0.340 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2018 | 4048 | 0.330 |
Why?
|
| Dihematoporphyrin Ether | 3 | 2011 | 33 | 0.330 |
Why?
|
| Duodenum | 1 | 2012 | 486 | 0.330 |
Why?
|
| Neuroendocrine Tumors | 3 | 2022 | 650 | 0.330 |
Why?
|
| Ampulla of Vater | 4 | 2015 | 149 | 0.330 |
Why?
|
| Influenza, Human | 1 | 2020 | 1528 | 0.330 |
Why?
|
| Neoadjuvant Therapy | 9 | 2024 | 2821 | 0.330 |
Why?
|
| DNA Mutational Analysis | 10 | 2021 | 4107 | 0.330 |
Why?
|
| Deoxycytidine | 3 | 2020 | 873 | 0.320 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 1765 | 0.320 |
Why?
|
| Chromogranins | 3 | 2018 | 161 | 0.310 |
Why?
|
| Lung Diseases | 7 | 2021 | 1915 | 0.310 |
Why?
|
| Autoimmune Diseases | 8 | 2011 | 2250 | 0.310 |
Why?
|
| Mucin-1 | 2 | 2018 | 539 | 0.310 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 695 | 0.310 |
Why?
|
| Analgesics | 1 | 2015 | 1065 | 0.300 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2023 | 2471 | 0.300 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 8 | 2023 | 895 | 0.300 |
Why?
|
| Gastritis | 3 | 2019 | 198 | 0.300 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2018 | 1596 | 0.300 |
Why?
|
| Lactams, Macrocyclic | 3 | 2022 | 315 | 0.300 |
Why?
|
| Disease-Free Survival | 9 | 2021 | 6828 | 0.300 |
Why?
|
| Neoplastic Cells, Circulating | 4 | 2016 | 938 | 0.300 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 104 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2022 | 2828 | 0.290 |
Why?
|
| Tumor Burden | 8 | 2019 | 1895 | 0.290 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 3 | 2018 | 195 | 0.290 |
Why?
|
| Bronchoscopy | 4 | 2021 | 911 | 0.290 |
Why?
|
| Photosensitizing Agents | 4 | 2011 | 618 | 0.290 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2009 | 265 | 0.290 |
Why?
|
| Bile Duct Neoplasms | 4 | 2017 | 602 | 0.290 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2018 | 6544 | 0.290 |
Why?
|
| Lymphatic Metastasis | 8 | 2024 | 2943 | 0.290 |
Why?
|
| Tracheal Neoplasms | 2 | 2019 | 123 | 0.280 |
Why?
|
| Endoscopy | 4 | 2017 | 1838 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2024 | 4550 | 0.280 |
Why?
|
| Radiography | 12 | 2018 | 6965 | 0.280 |
Why?
|
| Solitary Fibrous Tumor, Pleural | 2 | 2019 | 25 | 0.280 |
Why?
|
| Acetamides | 2 | 2020 | 256 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 4 | 2015 | 1484 | 0.270 |
Why?
|
| Esophageal Diseases | 4 | 2012 | 168 | 0.270 |
Why?
|
| Stomach Diseases | 2 | 2007 | 133 | 0.270 |
Why?
|
| Azepines | 2 | 2020 | 330 | 0.270 |
Why?
|
| Metaplasia | 5 | 2016 | 320 | 0.270 |
Why?
|
| Neoplasms | 9 | 2022 | 22072 | 0.270 |
Why?
|
| Transcription Factors | 5 | 2023 | 12103 | 0.270 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2019 | 1115 | 0.260 |
Why?
|
| Survival Rate | 16 | 2024 | 12808 | 0.260 |
Why?
|
| Duodenitis | 2 | 2020 | 20 | 0.260 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2007 | 867 | 0.260 |
Why?
|
| CA-19-9 Antigen | 3 | 2022 | 106 | 0.260 |
Why?
|
| Cytoskeletal Proteins | 2 | 2018 | 1343 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3085 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3205 | 0.250 |
Why?
|
| Common Bile Duct Neoplasms | 3 | 2015 | 120 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2013 | 727 | 0.250 |
Why?
|
| Mice | 45 | 2024 | 81208 | 0.250 |
Why?
|
| Abdominal Pain | 4 | 2020 | 1063 | 0.250 |
Why?
|
| Animals | 74 | 2024 | 167963 | 0.250 |
Why?
|
| Acrylamides | 2 | 2018 | 260 | 0.250 |
Why?
|
| Neutrophils | 2 | 2021 | 3767 | 0.250 |
Why?
|
| Colitis | 5 | 2019 | 1229 | 0.250 |
Why?
|
| Biopsy, Fine-Needle | 5 | 2016 | 1110 | 0.250 |
Why?
|
| Natural Orifice Endoscopic Surgery | 3 | 2011 | 119 | 0.240 |
Why?
|
| Preoperative Period | 5 | 2022 | 555 | 0.240 |
Why?
|
| Microscopy, Confocal | 5 | 2017 | 1972 | 0.240 |
Why?
|
| Papillomavirus Infections | 3 | 2022 | 1607 | 0.240 |
Why?
|
| Cysts | 2 | 2023 | 683 | 0.240 |
Why?
|
| Antibody Specificity | 2 | 2019 | 1060 | 0.240 |
Why?
|
| Esophagectomy | 2 | 2009 | 466 | 0.240 |
Why?
|
| Hemangiosarcoma | 2 | 2023 | 216 | 0.230 |
Why?
|
| Adenomatous Polyps | 2 | 2019 | 108 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2019 | 346 | 0.230 |
Why?
|
| Liver | 5 | 2021 | 7509 | 0.230 |
Why?
|
| Intestine, Small | 4 | 2020 | 1207 | 0.230 |
Why?
|
| Cardia | 3 | 2014 | 59 | 0.230 |
Why?
|
| Neoplasm, Residual | 4 | 2021 | 1007 | 0.220 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 15289 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 8 | 2016 | 2803 | 0.220 |
Why?
|
| Respiratory Insufficiency | 2 | 2023 | 1231 | 0.220 |
Why?
|
| Mucin 5AC | 7 | 2020 | 97 | 0.220 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 1274 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2019 | 556 | 0.220 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 1 | 2023 | 49 | 0.220 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5125 | 0.220 |
Why?
|
| Young Adult | 30 | 2022 | 58741 | 0.220 |
Why?
|
| Signal Transduction | 18 | 2024 | 23376 | 0.220 |
Why?
|
| Cytomegalovirus | 1 | 2007 | 755 | 0.210 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2003 | 75 | 0.210 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2024 | 141 | 0.210 |
Why?
|
| Cytomegalovirus Infections | 2 | 2007 | 831 | 0.210 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2015 | 256 | 0.210 |
Why?
|
| Hepatitis, Chronic | 1 | 2003 | 52 | 0.210 |
Why?
|
| Bile Ducts | 2 | 2015 | 282 | 0.210 |
Why?
|
| Cystadenocarcinoma, Mucinous | 2 | 2013 | 50 | 0.210 |
Why?
|
| Fibrosis | 5 | 2024 | 2042 | 0.210 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 1557 | 0.210 |
Why?
|
| Swine | 20 | 2015 | 5899 | 0.210 |
Why?
|
| Cough | 2 | 2019 | 595 | 0.210 |
Why?
|
| Polyamines | 1 | 2023 | 133 | 0.210 |
Why?
|
| Survival Analysis | 12 | 2021 | 10182 | 0.210 |
Why?
|
| Colon | 2 | 2011 | 1788 | 0.200 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2021 | 3765 | 0.200 |
Why?
|
| Aniline Compounds | 3 | 2018 | 1069 | 0.200 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2017 | 331 | 0.200 |
Why?
|
| Respiratory Tract Infections | 2 | 2022 | 1007 | 0.200 |
Why?
|
| Sampling Studies | 2 | 2013 | 613 | 0.200 |
Why?
|
| Early Detection of Cancer | 3 | 2021 | 3202 | 0.200 |
Why?
|
| Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
| Lymph Node Excision | 4 | 2019 | 1303 | 0.190 |
Why?
|
| Treatment Outcome | 29 | 2024 | 65017 | 0.190 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2021 | 59 | 0.190 |
Why?
|
| Colitis, Ischemic | 1 | 2021 | 32 | 0.190 |
Why?
|
| Smad6 Protein | 1 | 2021 | 14 | 0.190 |
Why?
|
| Carcinoma, Signet Ring Cell | 2 | 2012 | 83 | 0.190 |
Why?
|
| Biology | 1 | 2023 | 290 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2016 | 8950 | 0.190 |
Why?
|
| Peritoneal Neoplasms | 2 | 2020 | 707 | 0.190 |
Why?
|
| Quinazolines | 5 | 2015 | 1363 | 0.190 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2021 | 72 | 0.190 |
Why?
|
| Hemosiderosis | 1 | 2021 | 66 | 0.190 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2021 | 62 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2023 | 376 | 0.180 |
Why?
|
| Oxonic Acid | 1 | 2020 | 31 | 0.180 |
Why?
|
| Kupffer Cells | 1 | 2021 | 143 | 0.180 |
Why?
|
| Tegafur | 1 | 2020 | 39 | 0.180 |
Why?
|
| Diagnostic Imaging | 6 | 2017 | 3527 | 0.180 |
Why?
|
| Nerve Tissue | 1 | 2021 | 78 | 0.180 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 194 | 0.180 |
Why?
|
| Cell Proliferation | 15 | 2020 | 10446 | 0.180 |
Why?
|
| Bronchial Neoplasms | 1 | 2021 | 110 | 0.180 |
Why?
|
| Plectin | 2 | 2010 | 14 | 0.180 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1902 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 7 | 2020 | 7475 | 0.180 |
Why?
|
| Palliative Care | 2 | 2015 | 3607 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2020 | 225 | 0.180 |
Why?
|
| Disease Models, Animal | 20 | 2019 | 18137 | 0.180 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 487 | 0.180 |
Why?
|
| DNA, Neoplasm | 4 | 2016 | 1745 | 0.180 |
Why?
|
| Enterocolitis | 1 | 2021 | 106 | 0.180 |
Why?
|
| Diarrhea | 4 | 2020 | 1319 | 0.180 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2020 | 3529 | 0.180 |
Why?
|
| Fluorouracil | 5 | 2023 | 1631 | 0.170 |
Why?
|
| Carcinoma, Small Cell | 1 | 2022 | 416 | 0.170 |
Why?
|
| Tumor Virus Infections | 1 | 2023 | 438 | 0.170 |
Why?
|
| Pancreaticoduodenectomy | 6 | 2021 | 508 | 0.170 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 267 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2017 | 2448 | 0.170 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2020 | 67 | 0.170 |
Why?
|
| Aortic Valve Prolapse | 1 | 2019 | 10 | 0.170 |
Why?
|
| Follow-Up Studies | 19 | 2021 | 39261 | 0.170 |
Why?
|
| Colonic Polyps | 2 | 2019 | 551 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2023 | 3616 | 0.170 |
Why?
|
| Phospholipase D | 1 | 2019 | 67 | 0.170 |
Why?
|
| Ketone Bodies | 1 | 2019 | 76 | 0.170 |
Why?
|
| Japan | 3 | 2020 | 1369 | 0.170 |
Why?
|
| Liver Neoplasms | 5 | 2015 | 4319 | 0.170 |
Why?
|
| Thoracoscopy | 2 | 2011 | 176 | 0.170 |
Why?
|
| Stomach | 3 | 2009 | 694 | 0.170 |
Why?
|
| Radiology | 2 | 2023 | 2102 | 0.170 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2019 | 53 | 0.170 |
Why?
|
| Chest Pain | 2 | 2019 | 1106 | 0.170 |
Why?
|
| Cryosurgery | 1 | 2024 | 475 | 0.160 |
Why?
|
| Asia | 1 | 2021 | 620 | 0.160 |
Why?
|
| Pleura | 1 | 2020 | 244 | 0.160 |
Why?
|
| Genomics | 5 | 2023 | 5794 | 0.160 |
Why?
|
| Nomograms | 2 | 2018 | 238 | 0.160 |
Why?
|
| Lymphocytosis | 2 | 2012 | 119 | 0.160 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2023 | 321 | 0.160 |
Why?
|
| Lipoylation | 1 | 2019 | 88 | 0.160 |
Why?
|
| Quinolines | 1 | 2024 | 759 | 0.160 |
Why?
|
| Stem Cells | 3 | 2019 | 3523 | 0.160 |
Why?
|
| Mice, Nude | 8 | 2020 | 3607 | 0.160 |
Why?
|
| Receptor, erbB-3 | 1 | 2019 | 143 | 0.160 |
Why?
|
| Pulmonary Medicine | 2 | 2017 | 221 | 0.160 |
Why?
|
| Calcitriol | 1 | 2020 | 297 | 0.160 |
Why?
|
| Dyspnea | 2 | 2019 | 1352 | 0.160 |
Why?
|
| Multiprotein Complexes | 3 | 2013 | 1120 | 0.160 |
Why?
|
| Immunophenotyping | 1 | 2003 | 1871 | 0.160 |
Why?
|
| Hemangioma | 1 | 2023 | 728 | 0.160 |
Why?
|
| Clone Cells | 1 | 2022 | 1660 | 0.160 |
Why?
|
| Collagen Type I | 2 | 2023 | 616 | 0.150 |
Why?
|
| Pneumothorax | 1 | 2022 | 379 | 0.150 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2018 | 24 | 0.150 |
Why?
|
| Crohn Disease | 3 | 2019 | 2275 | 0.150 |
Why?
|
| Histocytochemistry | 1 | 2019 | 700 | 0.150 |
Why?
|
| Prednisone | 2 | 2021 | 1565 | 0.150 |
Why?
|
| Colitis, Collagenous | 1 | 2018 | 25 | 0.150 |
Why?
|
| Jaundice | 3 | 2015 | 97 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2021 | 1135 | 0.150 |
Why?
|
| Molecular Probes | 2 | 2017 | 313 | 0.150 |
Why?
|
| RNA, Neoplasm | 1 | 2020 | 749 | 0.150 |
Why?
|
| Melanoma | 5 | 2024 | 5697 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2019 | 36290 | 0.150 |
Why?
|
| Cognition Disorders | 1 | 2012 | 3976 | 0.150 |
Why?
|
| Mucoproteins | 1 | 2017 | 49 | 0.150 |
Why?
|
| Glucocorticoids | 2 | 2021 | 2145 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 3 | 2016 | 1705 | 0.150 |
Why?
|
| Acyltransferases | 1 | 2019 | 305 | 0.150 |
Why?
|
| Polypharmacy | 1 | 2020 | 307 | 0.150 |
Why?
|
| Drug Therapy | 2 | 2018 | 504 | 0.150 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 359 | 0.150 |
Why?
|
| Rectal Neoplasms | 3 | 2018 | 1152 | 0.150 |
Why?
|
| bcl-X Protein | 3 | 2015 | 413 | 0.150 |
Why?
|
| Pancreatitis, Chronic | 4 | 2024 | 281 | 0.140 |
Why?
|
| Tyrosine | 2 | 2020 | 1438 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 2 | 2011 | 599 | 0.140 |
Why?
|
| Neoplasm Metastasis | 4 | 2024 | 4902 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11345 | 0.140 |
Why?
|
| Gene Amplification | 4 | 2015 | 1085 | 0.140 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2019 | 380 | 0.140 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2019 | 111 | 0.140 |
Why?
|
| Proto-Oncogenes | 1 | 2018 | 320 | 0.140 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2021 | 304 | 0.140 |
Why?
|
| Dermatomyositis | 2 | 1997 | 256 | 0.140 |
Why?
|
| Neurosciences | 1 | 2022 | 353 | 0.140 |
Why?
|
| Choristoma | 2 | 2012 | 207 | 0.140 |
Why?
|
| Fatty Acids | 3 | 2020 | 1804 | 0.140 |
Why?
|
| Antigens, CD | 3 | 2021 | 4000 | 0.140 |
Why?
|
| Liver Cirrhosis | 2 | 2009 | 1931 | 0.140 |
Why?
|
| Polymyositis | 1 | 1997 | 75 | 0.140 |
Why?
|
| Oncogene Proteins | 3 | 2017 | 719 | 0.140 |
Why?
|
| Azacitidine | 2 | 2017 | 334 | 0.140 |
Why?
|
| Image Enhancement | 5 | 2014 | 2881 | 0.140 |
Why?
|
| Disease Progression | 10 | 2024 | 13502 | 0.140 |
Why?
|
| Necrosis | 5 | 2013 | 1612 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2011 | 2421 | 0.140 |
Why?
|
| In Situ Hybridization | 4 | 2017 | 1900 | 0.140 |
Why?
|
| Microspheres | 2 | 2011 | 787 | 0.140 |
Why?
|
| Platelet Factor 4 | 1 | 2016 | 129 | 0.130 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 286 | 0.130 |
Why?
|
| Peritoneum | 1 | 2017 | 224 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 6 | 2014 | 6068 | 0.130 |
Why?
|
| Feasibility Studies | 13 | 2021 | 5201 | 0.130 |
Why?
|
| Apoptosis | 6 | 2020 | 9501 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 829 | 0.130 |
Why?
|
| DNA Methylation | 5 | 2017 | 4373 | 0.130 |
Why?
|
| Sulfonamides | 4 | 2015 | 1977 | 0.130 |
Why?
|
| Pneumonia | 2 | 2022 | 2131 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1098 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 483 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2022 | 807 | 0.130 |
Why?
|
| Pulmonary Alveoli | 2 | 2022 | 653 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2013 | 2058 | 0.130 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 341 | 0.130 |
Why?
|
| Adolescent | 24 | 2021 | 87810 | 0.130 |
Why?
|
| Skin Neoplasms | 4 | 2024 | 5799 | 0.130 |
Why?
|
| Fever | 4 | 2013 | 1617 | 0.130 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 12159 | 0.130 |
Why?
|
| Mucin-6 | 3 | 2016 | 15 | 0.130 |
Why?
|
| Epithelium | 3 | 2016 | 1605 | 0.130 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2015 | 66 | 0.130 |
Why?
|
| Leucovorin | 3 | 2023 | 641 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 4 | 2023 | 7408 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 2017 | 286 | 0.130 |
Why?
|
| Intestines | 3 | 2019 | 1907 | 0.130 |
Why?
|
| Artifacts | 1 | 2024 | 1898 | 0.130 |
Why?
|
| Aminopyridines | 4 | 2022 | 564 | 0.130 |
Why?
|
| Calgranulin B | 1 | 2015 | 86 | 0.120 |
Why?
|
| Genotype | 4 | 2016 | 12960 | 0.120 |
Why?
|
| Pyrimidines | 6 | 2020 | 3016 | 0.120 |
Why?
|
| Enteroendocrine Cells | 1 | 2016 | 77 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 877 | 0.120 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2015 | 192 | 0.120 |
Why?
|
| Living Donors | 1 | 1999 | 636 | 0.120 |
Why?
|
| Pelvic Neoplasms | 1 | 2017 | 248 | 0.120 |
Why?
|
| Graft Rejection | 2 | 2016 | 4426 | 0.120 |
Why?
|
| Proportional Hazards Models | 5 | 2021 | 12531 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2017 | 783 | 0.120 |
Why?
|
| Brain | 2 | 2012 | 26951 | 0.120 |
Why?
|
| Magnetite Nanoparticles | 2 | 2014 | 316 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1683 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2020 | 2025 | 0.120 |
Why?
|
| Retinoblastoma Protein | 2 | 2015 | 670 | 0.120 |
Why?
|
| Calcinosis | 2 | 2021 | 1476 | 0.120 |
Why?
|
| Lactams | 3 | 2022 | 154 | 0.120 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2015 | 586 | 0.120 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 352 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2014 | 2864 | 0.120 |
Why?
|
| Societies, Medical | 8 | 2020 | 3905 | 0.120 |
Why?
|
| Mediastinoscopy | 2 | 2011 | 29 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2015 | 642 | 0.110 |
Why?
|
| Europe | 1 | 2021 | 3441 | 0.110 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 688 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2022 | 1182 | 0.110 |
Why?
|
| Neoplasm Seeding | 1 | 2014 | 84 | 0.110 |
Why?
|
| Portal Vein | 2 | 2007 | 429 | 0.110 |
Why?
|
| Biopsy, Needle | 4 | 2017 | 1630 | 0.110 |
Why?
|
| Cell Movement | 4 | 2020 | 5206 | 0.110 |
Why?
|
| Caloric Restriction | 2 | 2013 | 296 | 0.110 |
Why?
|
| Mucous Membrane | 4 | 2010 | 657 | 0.110 |
Why?
|
| Ovarian Neoplasms | 3 | 2020 | 4878 | 0.110 |
Why?
|
| DNA Helicases | 2 | 2020 | 854 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2017 | 768 | 0.110 |
Why?
|
| Positron-Emission Tomography | 4 | 2017 | 6465 | 0.110 |
Why?
|
| Logistic Models | 4 | 2018 | 13314 | 0.110 |
Why?
|
| Frameshift Mutation | 1 | 2015 | 388 | 0.110 |
Why?
|
| Tumor Escape | 1 | 2016 | 370 | 0.110 |
Why?
|
| Biliary Tract | 1 | 2014 | 135 | 0.110 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 9411 | 0.110 |
Why?
|
| Mice, Knockout | 8 | 2024 | 14372 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 509 | 0.110 |
Why?
|
| Breast Neoplasms | 6 | 2019 | 21025 | 0.110 |
Why?
|
| Gastroscopy | 4 | 2010 | 209 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2021 | 2907 | 0.110 |
Why?
|
| Mice, SCID | 4 | 2020 | 2627 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 5 | 2020 | 6131 | 0.110 |
Why?
|
| Miniaturization | 1 | 2013 | 153 | 0.110 |
Why?
|
| Ferrosoferric Oxide | 1 | 2014 | 348 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1403 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 22023 | 0.100 |
Why?
|
| Heterozygote | 1 | 2019 | 2798 | 0.100 |
Why?
|
| Paclitaxel | 3 | 2019 | 1736 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 242 | 0.100 |
Why?
|
| Anemia, Pernicious | 1 | 2012 | 15 | 0.100 |
Why?
|
| Bronchogenic Cyst | 1 | 2012 | 28 | 0.100 |
Why?
|
| Metabolomics | 1 | 2021 | 1628 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 830 | 0.100 |
Why?
|
| Immunity, Humoral | 1 | 2016 | 604 | 0.100 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 122 | 0.100 |
Why?
|
| Genes, ras | 3 | 2018 | 655 | 0.100 |
Why?
|
| Stents | 3 | 2011 | 3314 | 0.100 |
Why?
|
| Loss of Heterozygosity | 3 | 2014 | 659 | 0.100 |
Why?
|
| Mass Screening | 2 | 2021 | 5423 | 0.100 |
Why?
|
| Paneth Cells | 1 | 2012 | 98 | 0.100 |
Why?
|
| Ethanol | 2 | 2009 | 1323 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2018 | 2533 | 0.100 |
Why?
|
| Cohort Studies | 12 | 2020 | 41335 | 0.100 |
Why?
|
| Ferric Compounds | 1 | 2013 | 377 | 0.100 |
Why?
|
| Phenotype | 9 | 2018 | 16546 | 0.100 |
Why?
|
| Laparoscopy | 2 | 2017 | 2147 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 550 | 0.100 |
Why?
|
| Microvilli | 2 | 2020 | 233 | 0.100 |
Why?
|
| Fatty Liver | 2 | 2009 | 778 | 0.100 |
Why?
|
| raf Kinases | 1 | 2012 | 118 | 0.100 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 91 | 0.100 |
Why?
|
| Erythrocyte Indices | 1 | 2012 | 145 | 0.100 |
Why?
|
| Automation, Laboratory | 1 | 2012 | 103 | 0.100 |
Why?
|
| Risk Assessment | 8 | 2021 | 24123 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 256 | 0.090 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 319 | 0.090 |
Why?
|
| Plasma Cells | 3 | 2011 | 591 | 0.090 |
Why?
|
| Prospective Studies | 15 | 2021 | 54303 | 0.090 |
Why?
|
| Guanine | 1 | 2012 | 278 | 0.090 |
Why?
|
| Glutamates | 1 | 2012 | 391 | 0.090 |
Why?
|
| Placenta | 1 | 2020 | 1702 | 0.090 |
Why?
|
| Pulmonary Infarction | 1 | 2010 | 11 | 0.090 |
Why?
|
| Lymphocytes | 3 | 2009 | 2611 | 0.090 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2011 | 62 | 0.090 |
Why?
|
| Algorithms | 4 | 2019 | 13981 | 0.090 |
Why?
|
| Ornithine | 2 | 2023 | 79 | 0.090 |
Why?
|
| Smad4 Protein | 3 | 2016 | 191 | 0.090 |
Why?
|
| Catheter Ablation | 2 | 2015 | 2758 | 0.090 |
Why?
|
| Frozen Sections | 2 | 2021 | 153 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 1407 | 0.090 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2011 | 74 | 0.090 |
Why?
|
| Lymph Nodes | 4 | 2020 | 3486 | 0.090 |
Why?
|
| Proctoscopy | 1 | 2010 | 40 | 0.090 |
Why?
|
| Medical Records | 1 | 2016 | 1407 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 2003 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2003 | 2299 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 8986 | 0.090 |
Why?
|
| Liver Failure, Acute | 1 | 2012 | 181 | 0.090 |
Why?
|
| Preoperative Care | 3 | 2018 | 2256 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2138 | 0.090 |
Why?
|
| Proteins | 2 | 2017 | 6029 | 0.090 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 936 | 0.090 |
Why?
|
| Cecal Diseases | 1 | 2010 | 49 | 0.090 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 270 | 0.090 |
Why?
|
| Azathioprine | 1 | 2011 | 356 | 0.090 |
Why?
|
| Databases, Factual | 4 | 2020 | 8035 | 0.090 |
Why?
|
| Carcinoembryonic Antigen | 3 | 2016 | 336 | 0.090 |
Why?
|
| Child | 13 | 2023 | 79806 | 0.090 |
Why?
|
| Hyperplasia | 3 | 2009 | 1155 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 568 | 0.090 |
Why?
|
| Professional Role | 1 | 2012 | 310 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3465 | 0.090 |
Why?
|
| Angiotensin II | 1 | 2013 | 849 | 0.090 |
Why?
|
| Hyperhidrosis | 1 | 2009 | 34 | 0.080 |
Why?
|
| Lectins | 1 | 2011 | 484 | 0.080 |
Why?
|
| Genetic Testing | 3 | 2015 | 3531 | 0.080 |
Why?
|
| Telepathology | 1 | 2009 | 77 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2003 | 2882 | 0.080 |
Why?
|
| Sympathectomy | 1 | 2009 | 93 | 0.080 |
Why?
|
| Cecum | 1 | 2010 | 232 | 0.080 |
Why?
|
| Dissection | 1 | 2011 | 298 | 0.080 |
Why?
|
| Liposomes | 2 | 2023 | 777 | 0.080 |
Why?
|
| Adipokines | 1 | 2011 | 311 | 0.080 |
Why?
|
| Watchful Waiting | 1 | 2013 | 510 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3334 | 0.080 |
Why?
|
| Appendix | 1 | 2010 | 110 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 346 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2013 | 3340 | 0.080 |
Why?
|
| Intussusception | 1 | 2010 | 115 | 0.080 |
Why?
|
| Lipoma | 1 | 2011 | 292 | 0.080 |
Why?
|
| Cell Communication | 3 | 2024 | 1653 | 0.080 |
Why?
|
| Radiography, Thoracic | 2 | 2015 | 1296 | 0.080 |
Why?
|
| Forecasting | 1 | 2017 | 2932 | 0.080 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2008 | 608 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2019 | 2014 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2125 | 0.080 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2009 | 77 | 0.080 |
Why?
|
| Polyvinyls | 2 | 2007 | 154 | 0.080 |
Why?
|
| Brachytherapy | 2 | 2008 | 1238 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2001 | 0.080 |
Why?
|
| CpG Islands | 2 | 2009 | 1221 | 0.080 |
Why?
|
| Neuropeptides | 1 | 2013 | 943 | 0.080 |
Why?
|
| Risk Factors | 10 | 2020 | 74359 | 0.080 |
Why?
|
| Herpesvirus 4, Human | 2 | 2016 | 1075 | 0.080 |
Why?
|
| Bronchiectasis | 1 | 2009 | 139 | 0.080 |
Why?
|
| Hematocrit | 1 | 2009 | 629 | 0.070 |
Why?
|
| ROC Curve | 4 | 2021 | 3568 | 0.070 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2007 | 23 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 1999 | 2325 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 10181 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2015 | 2208 | 0.070 |
Why?
|
| Yttrium Radioisotopes | 1 | 2008 | 107 | 0.070 |
Why?
|
| Lymphoma | 1 | 2017 | 1898 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2013 | 2932 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2012 | 1247 | 0.070 |
Why?
|
| Serine | 1 | 2011 | 830 | 0.070 |
Why?
|
| Bronchi | 3 | 2018 | 848 | 0.070 |
Why?
|
| Endoscopy, Digestive System | 2 | 2009 | 351 | 0.070 |
Why?
|
| Pilot Projects | 6 | 2021 | 8555 | 0.070 |
Why?
|
| Pharmaceutical Solutions | 1 | 2007 | 15 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 2012 | 858 | 0.070 |
Why?
|
| Epithelioid Cells | 1 | 2007 | 60 | 0.070 |
Why?
|
| Splenic Vein | 1 | 2007 | 30 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2019 | 11481 | 0.070 |
Why?
|
| Collagen | 3 | 2023 | 2636 | 0.070 |
Why?
|
| Gastrostomy | 1 | 2010 | 321 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2017 | 9716 | 0.070 |
Why?
|
| Digestive System Neoplasms | 1 | 2007 | 81 | 0.070 |
Why?
|
| Thiazoles | 1 | 2014 | 1511 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4573 | 0.070 |
Why?
|
| Camptothecin | 1 | 2011 | 590 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1894 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2007 | 246 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2016 | 1305 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 234 | 0.070 |
Why?
|
| Indoles | 2 | 2013 | 1829 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2013 | 1617 | 0.070 |
Why?
|
| Immune Complex Diseases | 1 | 2006 | 52 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2024 | 580 | 0.070 |
Why?
|
| Combined Modality Therapy | 5 | 2024 | 8552 | 0.070 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2011 | 861 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 615 | 0.070 |
Why?
|
| Immunoglobulin G | 5 | 2011 | 4541 | 0.070 |
Why?
|
| Massachusetts | 1 | 2020 | 8803 | 0.070 |
Why?
|
| Arginine | 2 | 2023 | 934 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2013 | 818 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2010 | 638 | 0.070 |
Why?
|
| Spleen | 1 | 2013 | 2298 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 2919 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1535 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2008 | 237 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2014 | 717 | 0.070 |
Why?
|
| United States | 6 | 2021 | 72461 | 0.070 |
Why?
|
| Embolization, Therapeutic | 2 | 2007 | 1413 | 0.070 |
Why?
|
| Immunoblotting | 3 | 2015 | 1649 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2017 | 2511 | 0.070 |
Why?
|
| Smoking | 3 | 2019 | 9073 | 0.070 |
Why?
|
| Wound Healing | 2 | 2015 | 2788 | 0.070 |
Why?
|
| Radiography, Abdominal | 1 | 2009 | 532 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 857 | 0.070 |
Why?
|
| Urogenital Neoplasms | 1 | 2007 | 135 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 3 | 2011 | 1502 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2018 | 17790 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2010 | 434 | 0.070 |
Why?
|
| RNA Interference | 4 | 2016 | 2846 | 0.070 |
Why?
|
| DNA Mismatch Repair | 1 | 2009 | 429 | 0.060 |
Why?
|
| Models, Animal | 5 | 2010 | 2117 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2016 | 2520 | 0.060 |
Why?
|
| Hepatic Encephalopathy | 1 | 2007 | 144 | 0.060 |
Why?
|
| Virus Latency | 1 | 2008 | 362 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 5785 | 0.060 |
Why?
|
| Comorbidity | 1 | 2020 | 10551 | 0.060 |
Why?
|
| Iatrogenic Disease | 1 | 2008 | 538 | 0.060 |
Why?
|
| Video Recording | 2 | 2009 | 955 | 0.060 |
Why?
|
| Cyclins | 1 | 2007 | 593 | 0.060 |
Why?
|
| Pancreatic Diseases | 1 | 2007 | 343 | 0.060 |
Why?
|
| Workflow | 2 | 2022 | 852 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 3075 | 0.060 |
Why?
|
| Rectum | 1 | 2010 | 895 | 0.060 |
Why?
|
| Mesentery | 1 | 2005 | 202 | 0.060 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2009 | 380 | 0.060 |
Why?
|
| Consensus | 3 | 2024 | 3113 | 0.060 |
Why?
|
| Energy Intake | 1 | 2012 | 2129 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 2332 | 0.060 |
Why?
|
| Bleomycin | 2 | 2017 | 495 | 0.060 |
Why?
|
| Microsurgery | 1 | 2010 | 796 | 0.060 |
Why?
|
| Mevalonic Acid | 1 | 2024 | 46 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3598 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2005 | 263 | 0.060 |
Why?
|
| Prosthesis Failure | 2 | 2015 | 1206 | 0.060 |
Why?
|
| Cell Line | 4 | 2021 | 15620 | 0.060 |
Why?
|
| Health Personnel | 1 | 2017 | 3310 | 0.060 |
Why?
|
| Octamer Transcription Factors | 1 | 2023 | 18 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2414 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11903 | 0.060 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2024 | 98 | 0.060 |
Why?
|
| Amyloidosis | 1 | 2010 | 817 | 0.060 |
Why?
|
| Creatinine | 1 | 2009 | 1903 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 1837 | 0.060 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2019 | 262 | 0.060 |
Why?
|
| Ribosomal Protein S6 | 2 | 2013 | 71 | 0.060 |
Why?
|
| Keratins | 1 | 2005 | 497 | 0.060 |
Why?
|
| Hypesthesia | 1 | 2024 | 107 | 0.060 |
Why?
|
| International Agencies | 2 | 2016 | 244 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 2012 | 878 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2021 | 1959 | 0.050 |
Why?
|
| Pandemics | 2 | 2020 | 8624 | 0.050 |
Why?
|
| Clinical Trials as Topic | 3 | 2022 | 8056 | 0.050 |
Why?
|
| Microscopy | 1 | 2008 | 885 | 0.050 |
Why?
|
| Genes, APC | 1 | 2003 | 145 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2019 | 1754 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 2222 | 0.050 |
Why?
|
| Contrast Media | 5 | 2019 | 5305 | 0.050 |
Why?
|
| Prevalence | 2 | 2017 | 15687 | 0.050 |
Why?
|
| Sulfones | 2 | 2016 | 447 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 626 | 0.050 |
Why?
|
| Cell Survival | 3 | 2019 | 5797 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 4673 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2007 | 1529 | 0.050 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2009 | 831 | 0.050 |
Why?
|
| Genetic Heterogeneity | 2 | 2017 | 724 | 0.050 |
Why?
|
| Mediastinum | 1 | 2023 | 266 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2013 | 5961 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2024 | 3215 | 0.050 |
Why?
|
| Computational Biology | 3 | 2021 | 3505 | 0.050 |
Why?
|
| Inflammation | 5 | 2024 | 10756 | 0.050 |
Why?
|
| Injections | 3 | 2011 | 830 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2013 | 1943 | 0.050 |
Why?
|
| Incidence | 2 | 2017 | 21392 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2003 | 218 | 0.050 |
Why?
|
| Time Factors | 6 | 2020 | 40165 | 0.050 |
Why?
|
| Human papillomavirus 18 | 1 | 2022 | 125 | 0.050 |
Why?
|
| Clozapine | 1 | 2005 | 506 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2008 | 2194 | 0.050 |
Why?
|
| Intestinal Diseases | 1 | 2006 | 506 | 0.050 |
Why?
|
| Serous Membrane | 1 | 2021 | 24 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2017 | 42063 | 0.050 |
Why?
|
| Piperazines | 3 | 2019 | 2525 | 0.050 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2022 | 114 | 0.050 |
Why?
|
| Guanidines | 1 | 2022 | 193 | 0.050 |
Why?
|
| Losartan | 1 | 2023 | 265 | 0.050 |
Why?
|
| Esters | 1 | 2022 | 211 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 9530 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2021 | 4122 | 0.050 |
Why?
|
| Alcoholism | 1 | 2012 | 1961 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2007 | 1513 | 0.050 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 1021 | 0.050 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 506 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2021 | 220 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2019 | 8313 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2020 | 161 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2005 | 559 | 0.040 |
Why?
|
| Human papillomavirus 16 | 1 | 2022 | 265 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2016 | 631 | 0.040 |
Why?
|
| Genome, Human | 2 | 2015 | 4417 | 0.040 |
Why?
|
| Aging | 1 | 2019 | 8651 | 0.040 |
Why?
|
| Risk | 1 | 2012 | 9631 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 158 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 10827 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2007 | 1131 | 0.040 |
Why?
|
| Angiography | 1 | 2005 | 1605 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 1245 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1810 | 0.040 |
Why?
|
| Receptors, CXCR | 1 | 2020 | 52 | 0.040 |
Why?
|
| Patient Selection | 1 | 2012 | 4283 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2019 | 15 | 0.040 |
Why?
|
| Infant | 3 | 2012 | 36060 | 0.040 |
Why?
|
| North America | 2 | 2018 | 1284 | 0.040 |
Why?
|
| Gene Dosage | 2 | 2015 | 1218 | 0.040 |
Why?
|
| Germ-Line Mutation | 2 | 2009 | 1841 | 0.040 |
Why?
|
| Coronary Restenosis | 1 | 2003 | 426 | 0.040 |
Why?
|
| Chemokines | 1 | 2024 | 962 | 0.040 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2019 | 74 | 0.040 |
Why?
|
| Mediastinal Neoplasms | 1 | 2002 | 402 | 0.040 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1999 | 141 | 0.040 |
Why?
|
| Tissue Preservation | 1 | 1999 | 174 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 1919 | 0.040 |
Why?
|
| Pneumonectomy | 2 | 2020 | 1111 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2006 | 816 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 454 | 0.040 |
Why?
|
| Recurrence | 4 | 2015 | 8482 | 0.040 |
Why?
|
| Blood Group Incompatibility | 1 | 1999 | 135 | 0.040 |
Why?
|
| Enzyme Repression | 1 | 2018 | 30 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5889 | 0.040 |
Why?
|
| Cholangitis | 1 | 1999 | 113 | 0.040 |
Why?
|
| Hedgehog Proteins | 2 | 2016 | 769 | 0.040 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2019 | 89 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2007 | 2440 | 0.040 |
Why?
|
| Histocompatibility | 1 | 1999 | 316 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 361 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2019 | 361 | 0.040 |
Why?
|
| Benzamides | 2 | 2015 | 1369 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2022 | 582 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 4166 | 0.040 |
Why?
|
| Hematoxylin | 1 | 2018 | 60 | 0.040 |
Why?
|
| Ethylnitrosourea | 1 | 2018 | 51 | 0.040 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2018 | 69 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2022 | 755 | 0.040 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2018 | 101 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2022 | 494 | 0.040 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 210 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2007 | 1299 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 454 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2012 | 5990 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3539 | 0.040 |
Why?
|
| Macrophages | 1 | 2013 | 5745 | 0.040 |
Why?
|
| Point Mutation | 2 | 2015 | 1594 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2010 | 2159 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2016 | 2913 | 0.040 |
Why?
|
| Sigmoidoscopy | 1 | 2018 | 150 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 372 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2009 | 3301 | 0.040 |
Why?
|
| Endoderm | 1 | 2018 | 160 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 1139 | 0.040 |
Why?
|
| Medical Oncology | 2 | 2022 | 2313 | 0.040 |
Why?
|
| Transfection | 2 | 2016 | 5781 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 789 | 0.040 |
Why?
|
| Popliteal Cyst | 1 | 1996 | 8 | 0.040 |
Why?
|
| Mucin-2 | 2 | 2008 | 50 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1893 | 0.030 |
Why?
|
| Oncogene Fusion | 1 | 2017 | 81 | 0.030 |
Why?
|
| Phthalazines | 1 | 2019 | 383 | 0.030 |
Why?
|
| Sus scrofa | 2 | 2010 | 433 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2282 | 0.030 |
Why?
|
| Amylases | 1 | 2016 | 169 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 402 | 0.030 |
Why?
|
| Genes, erbB-2 | 1 | 2017 | 162 | 0.030 |
Why?
|
| Gallium Radioisotopes | 1 | 2017 | 195 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2022 | 1117 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2007 | 3143 | 0.030 |
Why?
|
| Cricoid Cartilage | 1 | 1996 | 69 | 0.030 |
Why?
|
| Pharyngeal Muscles | 1 | 1996 | 81 | 0.030 |
Why?
|
| Purines | 1 | 2019 | 605 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2019 | 1167 | 0.030 |
Why?
|
| Thrombophlebitis | 1 | 1996 | 288 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2016 | 145 | 0.030 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 307 | 0.030 |
Why?
|
| Neprilysin | 2 | 2009 | 472 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1999 | 533 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2016 | 167 | 0.030 |
Why?
|
| Cisplatin | 2 | 2019 | 1644 | 0.030 |
Why?
|
| Ovary | 1 | 2020 | 958 | 0.030 |
Why?
|
| Genes, cdc | 1 | 2016 | 115 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 1612 | 0.030 |
Why?
|
| Cell Count | 2 | 2012 | 1835 | 0.030 |
Why?
|
| Sirolimus | 2 | 2013 | 1547 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 805 | 0.030 |
Why?
|
| Bronchography | 1 | 1995 | 76 | 0.030 |
Why?
|
| Cystadenoma | 1 | 2015 | 79 | 0.030 |
Why?
|
| Injections, Intralesional | 2 | 2006 | 278 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2021 | 1326 | 0.030 |
Why?
|
| Imidazoles | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Forms and Records Control | 1 | 2016 | 158 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2020 | 728 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2640 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2019 | 9287 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 1753 | 0.030 |
Why?
|
| Genes, p16 | 1 | 2015 | 159 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2015 | 68 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 12922 | 0.030 |
Why?
|
| World Health Organization | 1 | 2021 | 1312 | 0.030 |
Why?
|
| Genes, myc | 1 | 2016 | 395 | 0.030 |
Why?
|
| Regeneration | 2 | 2015 | 1506 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2019 | 743 | 0.030 |
Why?
|
| Cysteine | 1 | 2019 | 895 | 0.030 |
Why?
|
| Computer-Assisted Instruction | 1 | 2017 | 362 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2016 | 258 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2014 | 145 | 0.030 |
Why?
|
| Filtration | 1 | 2015 | 229 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 105 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 772 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2007 | 4938 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 410 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2019 | 983 | 0.030 |
Why?
|
| Hepatitis B | 1 | 1999 | 701 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2013 | 5039 | 0.030 |
Why?
|
| Receptor, erbB-2 | 2 | 2015 | 2554 | 0.030 |
Why?
|
| Choroid Neoplasms | 1 | 1995 | 177 | 0.030 |
Why?
|
| Collagen Diseases | 1 | 1994 | 39 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 1189 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 453 | 0.030 |
Why?
|
| DNA | 1 | 2007 | 7233 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2018 | 1089 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2004 | 2049 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 367 | 0.030 |
Why?
|
| Age Factors | 3 | 2017 | 18416 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2014 | 202 | 0.030 |
Why?
|
| Pharynx | 1 | 1996 | 432 | 0.030 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 307 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 768 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2380 | 0.030 |
Why?
|
| Click Chemistry | 1 | 2013 | 95 | 0.030 |
Why?
|
| Molecular Probe Techniques | 1 | 2013 | 117 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2018 | 716 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2017 | 795 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2019 | 2209 | 0.030 |
Why?
|
| Acute Disease | 3 | 2015 | 7269 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2012 | 16 | 0.030 |
Why?
|
| Pyrophosphatases | 1 | 2013 | 139 | 0.030 |
Why?
|
| Teaching | 1 | 2020 | 1169 | 0.030 |
Why?
|
| Ilium | 1 | 2013 | 154 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2013 | 135 | 0.030 |
Why?
|
| Thymidylate Synthase | 1 | 2012 | 74 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.030 |
Why?
|
| Mitochondria | 2 | 2017 | 3600 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 608 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 529 | 0.030 |
Why?
|
| Hepatectomy | 2 | 2006 | 559 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2016 | 565 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1229 | 0.030 |
Why?
|
| Thymectomy | 1 | 2012 | 194 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2020 | 2838 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 3061 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2012 | 190 | 0.020 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2011 | 37 | 0.020 |
Why?
|
| Sternotomy | 1 | 2012 | 128 | 0.020 |
Why?
|
| Callitrichinae | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cadherins | 1 | 2016 | 898 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2210 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2015 | 1578 | 0.020 |
Why?
|
| Ketoglutaric Acids | 1 | 2011 | 75 | 0.020 |
Why?
|
| Paresthesia | 1 | 2012 | 162 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 384 | 0.020 |
Why?
|
| Radiotherapy Dosage | 2 | 2010 | 2897 | 0.020 |
Why?
|
| Postoperative Complications | 5 | 2015 | 15697 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2020 | 2299 | 0.020 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2012 | 119 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1617 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 858 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 1996 | 520 | 0.020 |
Why?
|
| Reoperation | 1 | 2021 | 4291 | 0.020 |
Why?
|
| Gastroscopes | 1 | 2010 | 19 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3157 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 616 | 0.020 |
Why?
|
| Sphingosine | 1 | 2013 | 308 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 277 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 468 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4264 | 0.020 |
Why?
|
| Hamartoma | 1 | 2013 | 235 | 0.020 |
Why?
|
| Kidney | 3 | 2017 | 7064 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 698 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2010 | 23 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 713 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1459 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 1996 | 626 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4713 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2013 | 339 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1737 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2011 | 230 | 0.020 |
Why?
|
| Reference Standards | 1 | 2014 | 1004 | 0.020 |
Why?
|
| Bronchiolitis | 1 | 1996 | 481 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2016 | 2221 | 0.020 |
Why?
|
| Exons | 1 | 2016 | 2388 | 0.020 |
Why?
|
| Western World | 1 | 2009 | 27 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 998 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 330 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 326 | 0.020 |
Why?
|
| Syncope | 1 | 2012 | 428 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2022 | 3061 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1726 | 0.020 |
Why?
|
| Cell Separation | 1 | 2015 | 1720 | 0.020 |
Why?
|
| Hepatitis C | 1 | 1999 | 1579 | 0.020 |
Why?
|
| Hemoptysis | 1 | 2010 | 152 | 0.020 |
Why?
|
| Esophagitis | 1 | 2010 | 163 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1889 | 0.020 |
Why?
|
| Boston | 2 | 2017 | 9280 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 2379 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2414 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2011 | 383 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2005 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2009 | 271 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 1755 | 0.020 |
Why?
|
| Family | 1 | 1999 | 3189 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3602 | 0.020 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2010 | 165 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 956 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 218 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2017 | 2007 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1881 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 698 | 0.020 |
Why?
|
| Cytarabine | 1 | 2010 | 696 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1428 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3084 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2014 | 2362 | 0.020 |
Why?
|
| Prescriptions | 1 | 2010 | 388 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2008 | 197 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2009 | 363 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3696 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Venous Pressure | 1 | 2007 | 57 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2015 | 22053 | 0.020 |
Why?
|
| Anal Canal | 1 | 2010 | 372 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 877 | 0.020 |
Why?
|
| Computer Systems | 1 | 2008 | 470 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 6216 | 0.020 |
Why?
|
| Submandibular Gland | 1 | 2006 | 87 | 0.020 |
Why?
|
| Abscess | 1 | 2010 | 605 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 1738 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 3604 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1173 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3775 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 611 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 1156 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2005 | 6915 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2019 | 12914 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2010 | 983 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2394 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7343 | 0.020 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2006 | 64 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1553 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2011 | 665 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2011 | 786 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 1167 | 0.020 |
Why?
|
| Rats | 1 | 2022 | 23711 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2007 | 451 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1067 | 0.020 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2011 | 453 | 0.020 |
Why?
|
| Keratin-20 | 1 | 2005 | 31 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1055 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 1928 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1600 | 0.020 |
Why?
|
| Keratin-7 | 1 | 2005 | 55 | 0.020 |
Why?
|
| Genetic Variation | 2 | 2012 | 6551 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 1077 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3969 | 0.020 |
Why?
|
| Lasers | 1 | 2009 | 952 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2005 | 130 | 0.020 |
Why?
|
| RNA | 1 | 2015 | 2722 | 0.020 |
Why?
|
| Pyloric Antrum | 1 | 2005 | 66 | 0.020 |
Why?
|
| International Cooperation | 1 | 2011 | 1433 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8469 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 513 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2008 | 658 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2013 | 1204 | 0.020 |
Why?
|
| Cell Division | 1 | 2012 | 4463 | 0.010 |
Why?
|
| Longevity | 1 | 2012 | 1050 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5325 | 0.010 |
Why?
|
| Hypotension | 1 | 2010 | 883 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2009 | 930 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 2005 | 234 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 2005 | 302 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2011 | 1479 | 0.010 |
Why?
|
| Curriculum | 1 | 2017 | 3718 | 0.010 |
Why?
|
| Adenoma, Villous | 1 | 2003 | 14 | 0.010 |
Why?
|
| Glutens | 1 | 2006 | 240 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1697 | 0.010 |
Why?
|
| Software | 1 | 2018 | 4419 | 0.010 |
Why?
|
| Protein Binding | 1 | 2016 | 9335 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 2006 | 311 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3047 | 0.010 |
Why?
|
| Bacteremia | 1 | 2010 | 980 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3758 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6898 | 0.010 |
Why?
|
| Goblet Cells | 1 | 2006 | 299 | 0.010 |
Why?
|
| Catheterization | 1 | 2008 | 1432 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1996 | 2543 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2005 | 877 | 0.010 |
Why?
|
| Peptides | 1 | 2015 | 4354 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 1544 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 3986 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 2012 | 1499 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9585 | 0.010 |
Why?
|
| Pelvis | 1 | 2007 | 743 | 0.010 |
Why?
|
| Atherectomy, Coronary | 1 | 2003 | 146 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2012 | 2255 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2011 | 2488 | 0.010 |
Why?
|
| Anemia | 1 | 2012 | 1511 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2010 | 4035 | 0.010 |
Why?
|
| Equipment Design | 1 | 2010 | 3520 | 0.010 |
Why?
|
| Morbidity | 1 | 2007 | 1765 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2017 | 4783 | 0.010 |
Why?
|
| Abdomen | 1 | 2007 | 1130 | 0.010 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 1660 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2011 | 2283 | 0.010 |
Why?
|
| Weight Loss | 1 | 2012 | 2686 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 1186 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 3387 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7588 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4357 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2003 | 624 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 6180 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3446 | 0.010 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 2165 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5496 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2006 | 697 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 29749 | 0.010 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2002 | 348 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25942 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 12446 | 0.010 |
Why?
|
| Tin Compounds | 1 | 1996 | 8 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 3620 | 0.010 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1996 | 66 | 0.010 |
Why?
|
| Length of Stay | 1 | 2010 | 6479 | 0.010 |
Why?
|
| Vindesine | 1 | 1995 | 12 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 17624 | 0.010 |
Why?
|
| Pedigree | 1 | 2003 | 4578 | 0.010 |
Why?
|
| Poliomyelitis | 1 | 1996 | 94 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 18957 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 15789 | 0.010 |
Why?
|
| Phlebography | 1 | 1996 | 325 | 0.010 |
Why?
|
| Sex Factors | 1 | 2009 | 10547 | 0.010 |
Why?
|
| Mitomycin | 1 | 1995 | 262 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1996 | 674 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3484 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 1975 | 0.010 |
Why?
|
| Carboplatin | 1 | 1995 | 788 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15840 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2003 | 4563 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 12293 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1995 | 4312 | 0.000 |
Why?
|